Crossmark

Interstitial pneumonitis associated with combined regimen of immunotherapy and conventional therapies—pharmacovigilance database analysis with real-world data validation

Crossref DOI link: https://doi.org/10.1186/s12916-022-02713-6

Published Online: 2023-01-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Guo, Xue-Jun

Cai, Xiao-Ting

Rong, Zi-Xuan

Zhang, Yan-Pei

Wen, Yu-Xiang

Bai, Xue

Wang, Jian

Fu, Qiang John

Guo, Ze-Qin

Long, Li-Li

Ma, Si-Cong

Tang, Xin-Ran

Liu, Li

Guan, Jian

Dong, Zhong-Yi http://orcid.org/0000-0001-9967-0060
Wu, De-Hua
License Information

Text and Data Mining valid from 2023-01-05

Version of Record valid from 2023-01-05
More Information

Article History

Received: 14 April 2022

Accepted: 14 December 2022

First Online: 5 January 2023

Declarations

:

: Since data in FAERS are anonymized and publicly available, the requirements for obtaining informed consent and institutional review board approval were waived. As the validation cohort, this retrospective, observational study was approved by the institutional review board of the Nanfang Hospital of Southern Medical University with exemption from informed consent (NFEC-2021-003).

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below